International Journal of Pharmaceutical Sciences and Nanotechnology (IJPSN)

Open Access Open Access  Restricted Access Subscription Access

Current Drug Shortages in the United States


Affiliations
1 Editor-in-Chief, International Journal of Pharmaceutical Sciences and Nanotechnology, and Associate Professor, Department of Neuroscience and Experimental Therapeutics, Texas A&M University System Health Science Center, College of Medicine, College Station, Texas,, United States
 

This article provides an overview of current drug shortages in the United States as of November 5, 2011. IMS report finds cancer drugs and generic injectables are scarcest, calls for early warning system to prevent shortages from disrupting patient care. Shortages are worst among a handful of 75 drugs, including biologicals, vitamins, antibiotics, antiemetics, antihypertensive agents, narcotic analgesics and CNS drugs. Most of the drugs on the list are generic intravenous or injectable drugs given to patients in hospitals. Manufacturers voluntarily report shortages to FDA. There are several reasons for current drug shortages. A major reason for these shortages is quality/manufacturing issues and growing demand for these drug products. Drug shortage is a long-standing problem inthe US and in many countries worldwide. There is a great need to develop a plan addressing this critical issue.

Keywords

Drug shortage; APIs; antibiotics; anticancer agents; biologicals; supplements
User
Notifications
Font Size

  • Bernhard B (2011). U.S. faces big drug shortage. The Eagle, October 31st: A7-A7.

  • Conde C (2011). Drug shortage. Tex Med 107(10):23-29.

  • Federico FA, Benjamin B and Cohen M (2011). Drug shortages: a patient safety crisis. Leaders must plan ahead to address this critical issue. Healthc Exec 26(5):80-83.

  • Kaakeh R, Sweet BV, Reilly C, Bush C, DeLoach S, Higgins B, Clark AM and Stevenson J (2011). Impact of drug shortages on U.S. health systems. Am J Health Syst Pharm 68(19):1811-1819.

  • Mitka M (2011). FDA, US hospital and pharmacy groups report drug shortages a growing problem. JAMA 306(10):1069-1070.


Abstract Views: 68

PDF Views: 39




  • Current Drug Shortages in the United States

Abstract Views: 68  |  PDF Views: 39

Authors

D. Samba Reddy
Editor-in-Chief, International Journal of Pharmaceutical Sciences and Nanotechnology, and Associate Professor, Department of Neuroscience and Experimental Therapeutics, Texas A&M University System Health Science Center, College of Medicine, College Station, Texas,, United States

Abstract


This article provides an overview of current drug shortages in the United States as of November 5, 2011. IMS report finds cancer drugs and generic injectables are scarcest, calls for early warning system to prevent shortages from disrupting patient care. Shortages are worst among a handful of 75 drugs, including biologicals, vitamins, antibiotics, antiemetics, antihypertensive agents, narcotic analgesics and CNS drugs. Most of the drugs on the list are generic intravenous or injectable drugs given to patients in hospitals. Manufacturers voluntarily report shortages to FDA. There are several reasons for current drug shortages. A major reason for these shortages is quality/manufacturing issues and growing demand for these drug products. Drug shortage is a long-standing problem inthe US and in many countries worldwide. There is a great need to develop a plan addressing this critical issue.

Keywords


Drug shortage; APIs; antibiotics; anticancer agents; biologicals; supplements

References